MIIM
AMPH icon

Mesirow Institutional Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mesirow Institutional Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$14.1M Sell
380,389
-33,560
-8% -$1.53M 1.09% 43
2024
Q3 		$20.1M Buy
413,949
+60,502
+17% +$2.66M 1.53% 3
2024
Q2 		$14.1M Buy
353,447
+3,153
+0.9% +$131K 1.24% 31
2024
Q1 		$15.4M Buy
350,294
+97,463
+39% +$5.03M 1.37% 20
2023
Q4 		$15.6M Buy
252,831
+69,026
+38% +$3.63M 1.46% 16
2023
Q3 		$8.45M Buy
183,805
+54,343
+42% +$2.96M 0.86% 68
2023
Q2 		$7.44M Sell
129,462
-196,207
-60% -$8.7M 0.77% 74
2023
Q1 		$12.2M Sell
325,669
-48,745
-13% -$1.6M 1.33% 14
2022
Q4 		$10.5M Sell
374,414
-2,685
-0.7% -$78K 1.38% 13
2022
Q3 		$10.6M Buy
+377,099
New +$12.3M 1.54% 14

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Mesirow Institutional Investment Management's AMPH Position: Q4 2024 in Review

Mesirow Institutional Investment Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 8.1% in Q4 2024, selling an estimated $1.53M and leaving 380,389 shares worth $14.1M. The position accounts for 1.09% of the portfolio, ranked #43.

Mesirow Institutional Investment Management first reported a position in AMPH in Q3 2022 and has held it in 10 quarters since. The position peaked at $20.1M in Q3 2024. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Mesirow Institutional Investment Management held 380,389 shares of Amphastar Pharmaceuticals worth $14.1M as of Q4 2024.
  • Mesirow Institutional Investment Management sold 33,560 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $1.53M.
  • Amphastar Pharmaceuticals made up 1.09% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #43 holding.
  • Mesirow Institutional Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
  • Mesirow Institutional Investment Management's Amphastar Pharmaceuticals position peaked at $20.1M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.